EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.15.1 | ellagic acid | IC50: 0.4 mM | Sus scrofa | |
3.4.15.1 | hyperosid | IC50: 0.2 mM | Sus scrofa | |
3.4.15.1 | isoquercitrin | IC50: 0.3 mM | Sus scrofa | |
3.4.15.1 | lisinopril | IC50: 1 nM | Sus scrofa | |
3.4.15.1 | additional information | compounds from Epilobium angustifolium inhibit. Taking into account the role of these peptidase in prostate diseases, the results may partly support and explain the use of Epilobium extracts in folk medicine | Sus scrofa | |
3.4.15.1 | oenothein B | IC50: 0.25 mM | Sus scrofa | |
3.4.15.1 | quercetin 3-O-(6''-galloyl)-galactoside | IC50: 0.16 mM | Sus scrofa | |
3.4.15.1 | quercitrin | IC50: 0.25 mM | Sus scrofa | |
3.4.15.1 | quercitrin glucuronide | IC50: 0.2 mM | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.15.1 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.15.1 | sperm | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.15.1 | hippuryl-His-Leu + H2O | - |
Sus scrofa | hippuric acid + His-Leu | - |
? |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.15.1 | 0.000001 | - |
IC50: 1 nM | Sus scrofa | lisinopril | |
3.4.15.1 | 0.16 | - |
IC50: 0.16 mM | Sus scrofa | quercetin 3-O-(6''-galloyl)-galactoside | |
3.4.15.1 | 0.2 | - |
IC50: 0.2 mM | Sus scrofa | hyperosid | |
3.4.15.1 | 0.2 | - |
IC50: 0.2 mM | Sus scrofa | quercitrin glucuronide | |
3.4.15.1 | 0.25 | - |
IC50: 0.25 mM | Sus scrofa | quercitrin | |
3.4.15.1 | 0.25 | - |
IC50: 0.25 mM | Sus scrofa | oenothein B | |
3.4.15.1 | 0.3 | - |
IC50: 0.3 mM | Sus scrofa | isoquercitrin | |
3.4.15.1 | 0.4 | - |
IC50: 0.4 mM | Sus scrofa | ellagic acid |